Login / Signup

Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States.

Vincent Lo ReNoelle M CocorosRebecca A HubbardSarah K DutcherCraig W NewcombJohn G ConnollySilvia Perez-VilarDena M CarbonariMaria E KempnerJosé J Hernández-MuñozAndrew B PetroneAllyson M PishkoMeighan E Rogers DriscollJames T BrashSean BurnettCatherine CohetMatthew DahlTerese A DeForAntonella DelmestriDjeneba Audrey DjiboTalita Duarte SallesLaura B HarringtonMelissa KampmanJennifer L KuntzXavier KurzNúria Mercadé-BesoraPamala A PawloskiPeter R RijnbeekSarah SeagerClaudia A SteinerKatia M C VerhammeFangyun WuYunping ZhouEdward BurnJ Michael PatersonDaniel Prieto Alhambra
Published in: Clinical epidemiology (2024)
There was heterogeneity by country in 90-day absolute risk of ATE and VTE after ambulatory COVID-19 diagnosis both before and during COVID-19 vaccine availability.
Keyphrases
  • coronavirus disease
  • venous thromboembolism
  • sars cov
  • blood pressure
  • single cell
  • quality improvement
  • transcription factor
  • respiratory syndrome coronavirus